Cargando…
Risk Factors for Bleeding and Clinical Ineffectiveness Associated With Clopidogrel Therapy: A Comprehensive Meta‐Analysis
Although clopidogrel is a frequently used antiplatelet medication to treat and prevent atherothrombotic disease, clinicians must balance its clinical effectiveness with the potential side effect of bleeding. However, many previous studies have evaluated beneficial and adverse factors separately. The...
Autores principales: | Nguyen, Khoa A., Eadon, Michael T., Yoo, Ryan, Milway, Evan, Kenneally, Allison, Fekete, Kevin, Oh, Hyun, Duong, Khanh, Whipple, Elizabeth C., Schleyer, Titus K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993261/ https://www.ncbi.nlm.nih.gov/pubmed/33202084 http://dx.doi.org/10.1111/cts.12926 |
Ejemplares similares
-
Impact of Clopidogrel Stop Interval on Major Adverse Bleeding Events in Cardiac Surgery
por: Huo, Bright, et al.
Publicado: (2021) -
Overstimulated and ineffective
por: Van Epps, Heather L.
Publicado: (2005) -
Small bowel ulcer bleeding due to suspected clopidogrel use in a patient with clopidogrel resistance: A case report
por: Lee, Sang Hoon, et al.
Publicado: (2021) -
Aspirin vs Clopidogrel: Antiplatelet Agent of Choice for Those With Recent Bleeding or at Risk for Gastrointestinal Bleed
por: Gosavi, Siddharth, et al.
Publicado: (2023) -
Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel
por: Kim, Gwang-Un, et al.
Publicado: (2021)